Korean J Dermatol.
2009 Mar;47(3):317-321.
Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome Caused by Topical Ophthalmic Use of Dorzolamide
- Affiliations
-
- 1Department of Dermatology, Jeju National University School of Medicine, Jeju, Korea. rulid@cheju.ac.kr
- 2Department of Infectious Disease, Jeju National University School of Medicine, Jeju, Korea.
Abstract
- Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are the potentially life-threatening, acute hypersensitivity reaction to inciting drugs. These diseases have been often associated with systemic carbonic anhydrase inhibitor such as acetazolamide or methazolamide in Korean and Japanese patients. Dorzolamide is a recently developed topical carbonic anhydrase inhibitor with few significant systemic adverse effects. To the best of our knowledge, there have been only a few reports of SJS or TEN caused by topical dorzolamide in the literature. We herein present two cases of TEN and one case of SJS related with topical use of dorzolamide. It should be emphasized that although rarely, topical dorzolamide may cause serious sulfonamide hypersensitivity such as SJS or TEN in the susceptible patient through the systemic absorption.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Toxic Epidermal Necrolysis Induced by the Topical Carbonic Anhydrase Inhibitors Brinzolamide and Dorzolamide
- T Cell Mediated Drug Hypersensitivity: Stevens Johnson Syndrome and Toxic Epidermal Necrolysis
- A Case of Toxic Epidermal Necrolysis
- A comparative clinical study of toxic epidermal necrolysis and Stevens-Johnson syndrome
- Two Cases of HLA-B59(+) Stevens-Johnson Syndrome (SJS)-Toxic Epidermal Necrolysis (TEN) Associated with Methazolamide Treatment
